Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MA vs MRNA✓SelectedUSD · MRNAMA vs MRNA performance historyLatest closeAs of+0.08%11/16
Stock and ETF performance explorer

MA vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+252.5%
MRNA return
+878.5%
Excess return
-626.0%
Maximum drawdown
-41.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+0.1%-3.6%+3.7%+0.2%
7D+0.9%-20.0%+20.9%+1.3%
30D+7.2%-1.3%+8.4%+7.1%
3M+16.4%+240.0%-223.6%+11.8%
6M+34.3%+339.0%-304.6%+27.5%
YTD+16.7%+630.0%-613.3%+8.3%
1Y+22.0%+769.1%-747.0%+12.5%
3Y+69.6%+181.2%-111.6%+59.9%
5Y+84.5%-8.1%+92.6%+75.4%
All+252.5%+878.5%-626.0%+217.4%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling